Rockwell Medical, Inc. (RMTI) News

Rockwell Medical, Inc. (RMTI): $1.05

-0.04 (-3.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter RMTI News Items

RMTI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RMTI News Highlights

  • For RMTI, its 30 day story count is now at 3.
  • Over the past 8 days, the trend for RMTI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest RMTI News From Around the Web

Below are the latest news stories about ROCKWELL MEDICAL INC that investors may wish to consider to help them evaluate RMTI as an investment opportunity.

Rockwell Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

Rockwell Medical ( NASDAQ:RMTI ) Third Quarter 2022 Results Key Financial Results Revenue: US$18.7m (up 17% from 3Q...

Yahoo | November 17, 2022

Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results

WIXOM, Mich., November 14, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today provided an update on its overall business strategy and announced its financial and operational results for the third quarter ended September 30, 2022.

Yahoo | November 14, 2022

Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from Baxter

WIXOM, Mich., November 09, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company is reacquiring its distribution rights to its hemodialysis concentrates products from Baxter and has agreed to terminate the exclusive distribution agreement dated October 2, 2014. Exclusivity and other provi

Yahoo | November 9, 2022

Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14

WIXOM, Mich., October 17, 2022--Rockwell Medical, Inc. (Nasdaq:RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that it will release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

Yahoo | October 17, 2022

Is Rockwell Medical, Inc. (NASDAQ:RMTI) Potentially Undervalued?

While Rockwell Medical, Inc. ( NASDAQ:RMTI ) might not be the most widely known stock at the moment, it saw significant...

Yahoo | October 13, 2022

Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

WIXOM, Mich., September 14, 2022--Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of stock options to purchase an aggregate of 66,000 shares of the Company’s common stock to three new employees (the "Induc

Yahoo | September 14, 2022

Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer

WIXOM, Mich., September 07, 2022--As SVP, Chief Corporate Affairs Officer, Heather is responsible for IR, PR, government affairs, patient advocacy, communications, and branding.

Yahoo | September 7, 2022

Are Investors Undervaluing Rockwell Medical, Inc. (NASDAQ:RMTI) By 46%?

How far off is Rockwell Medical, Inc. ( NASDAQ:RMTI ) from its intrinsic value? Using the most recent financial data...

Yahoo | September 2, 2022

Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Portage Biotech Inc (PRTG) and IN8bio (INAB)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rockwell Med (RMTI – Research Report), Portage Biotech Inc (PRTG – Research Report) and IN8bio (INAB – Research Report) with bullish sentiments. Rockwell Med (RMTI) H.C. Wainwright analyst Ram Selvaraju maintained a Buy rating on Rockwell Med today and set a price target of $8.00. The company's shares closed last Monday at $1.42, close to its 52-week low of $1.17. According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of -18.5% and a 26.3% success rate.

Brian Anderson on TipRanks | August 30, 2022

Analyst Hikes Price Target, Expects Rockwell Medical To Take Steps To Improve Debt Position

HC Wainwright has increased the price target on Rockwell Medical Inc (NASDAQ: RMTI) from $3 to $8, with a Buy rating, reflecting a 1-for-11 reverse stock split effected in May and a renewed focus on the hemodialysis concentrates business. Rockwell Medical recorded Q2 sales of $18.7 million, the highest quarterly revenue recorded by the company since its inception. The analyst believes that management's decision to prioritize stabilization of the established hemodialysis concentrates business sho

Yahoo | August 30, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6851 seconds.